Scher, Howard I.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Circulating Tumor Cells in Prostate Cancer: From Discovery to Clinical Utility

Pantel, Klaus, Hille, Claudia, Scher, Howard I.

Journal:

Clinical Chemistry

Year:

2019

Language:

english

File:

PDF, 934 KB

english, 2019

2

Methylphenidate for fatigue in ambulatory men with prostate cancer

Andrew J. Roth, Christian Nelson, Barry Rosenfeld, Howard Scher, Susan Slovin, Michael Morris, Noelle O'Shea, Gabrielle Arauz, William Breitbart

Journal:

Year:

2010

Language:

english

File:

PDF, 212 KB

english, 2010

3

Analytic and Clinical Validation of a Prostate Cancer–Enhanced Messenger RNA Detection Assay in Whole Blood as a Prognostic Biomarker for Survival

Danila, Daniel C., Anand, Aseem, Schultz, Nikolaus, Heller, Glenn, Wan, Mingliang, Sung, Clifford C., Dai, Charles, Khanin, Raya, Fleisher, Martin, Lilja, Hans, Scher, Howard I.

Journal:

European Urology

Year:

2014

Language:

english

File:

PDF, 1.60 MB

english, 2014

4

Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer

Brett S. Carver, Caren Chapinski, John Wongvipat, Haley Hieronymus, Yu Chen, Sarat Chandarlapaty, Vivek K. Arora, Carl Le, Jason Koutcher, Howard Scher, Peter T. Scardino, Neal Rosen, Charles L. Sawye

Journal:

Year:

2011

Language:

english

File:

PDF, 1.64 MB

english, 2011

5

Reliability of the Arch Height Index as a Measure of Foot Structure in Children

Drefus, Lisa C., Kedem, Paz, Mangan, Siobhan M., Scher, David M., Hillstrom, Howard J.

Journal:

Pediatric Physical Therapy

Year:

2017

Language:

english

File:

PDF, 152 KB

english, 2017

6

Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial

Fizazi, Karim, Scher, Howard I, Miller, Kurt, Basch, Ethan, Sternberg, Cora N, Cella, David, Forer, David, Hirmand, Mohammad, de Bono, Johann S

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 337 KB

english, 2014

7

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study

Karim Fizazi, Howard I Scher, Arturo Molina, Christopher J Logothetis, Kim N Chi, Robert J Jones, John N Staffurth, Scott North, Nicholas J Vogelzang, Fred Saad, Paul Mainwaring, Stephen Harland, Osca

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 295 KB

english, 2012

8

Primary squamous cell carcinoma of the prostate after radiation seed implantation for adenocarcinoma

Vincent A. Miller, Victor Reuter, Howard I. Scher

Journal:

Year:

1995

Language:

english

File:

PDF, 619 KB

english, 1995

9

Using Confirmatory Factor Analysis to Evaluate Construct Validity of the Brief Pain Inventory (BPI)

Thomas M. Atkinson, Barry D. Rosenfeld, Laura Sit, Tito R. Mendoza, Mike Fruscione, Dawn Lavene, Mary Shaw, Yuelin Li, Jennifer Hay, Charles S. Cleeland, Howard I. Scher, William S. Breitbart, Ethan B

Journal:

Journal of Pain and Symptom Management

Year:

2011

Language:

english

File:

PDF, 136 KB

english, 2011

10

Chromosome 16 in primary prostate cancer: A microsatellite analysis

Iman Osman, Howard Scher, Guido Dalbagni, Victor Reuter, Zuo-Feng Zhang, Carlos Cordon-Cardo

Journal:

International Journal of Cancer

Year:

1997

Language:

english

File:

PDF, 93 KB

english, 1997

11

Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target

Yu Chen, Nicola J Clegg, Howard I Scher

Journal:

The Lancet Oncology

Year:

2009

Language:

english

File:

PDF, 467 KB

english, 2009

12

Rapid screening for psychologic distress in men with prostate carcinoma : A pilot study

Andrew J. Roth, Alice B. Kornblith, Laure Batel-Copel, Elizabeth Peabody, Howard I. Scher, Jimmie C. Holland

Journal:

Year:

1998

Language:

english

File:

PDF, 80 KB

english, 1998

13

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study

Howard I Scher, Tomasz M Beer, Celestia S Higano, Aseem Anand, Mary-Ellen Taplin, Eleni Efstathiou, Dana Rathkopf, Julia Shelkey, Evan Y Yu, Joshi Alumkal, David Hung, Mohammad Hirmand, Lynn Seely, Mi

Journal:

Year:

2010

Language:

english

File:

PDF, 421 KB

english, 2010

14

Effect of Shoe Flexibility on Plantar Loading in Children Learning to Walk

Hillstrom, Howard J., Buckland, Melanie A., Slevin, Corinne M., Hafer, Jocelyn F., Root, Leon M., Backus, Sherry I., Kraszewski, Andrew P., Whitney, Kendrick A., Scher, David M., Song, Jinsup, Furmato

Journal:

Journal of the American Podiatric Medical Association

Year:

2013

Language:

english

File:

PDF, 628 KB

english, 2013

15

Apalutamide for the treatment of prostate cancer

Rathkopf, Dana E., Scher, Howard I.

Journal:

Expert Review of Anticancer Therapy

Year:

2018

Language:

english

File:

PDF, 1.39 MB

english, 2018

16

Clinical states in prostate cancer: toward a dynamic model of disease progression

Howard I. Scher, Glenn Heller

Journal:

Year:

2000

Language:

english

File:

PDF, 370 KB

english, 2000

17

Second-Line Chemotherapy for Prostate Cancer: Patient Characteristics and Survival

Beekman, Kathleen W., Fleming, Mark T., Scher, Howard I., Slovin, Susan F., Ishill, Nicole M., Heller, Glenn, Kelly, W. Kevin

Journal:

Clinical Prostate Cancer

Year:

2005

Language:

english

File:

PDF, 882 KB

english, 2005

18

Prevalence of Prostate Cancer Clinical States and Mortality in the United States: Estimates Using a Dynamic Progression Model

Scher, Howard I., Solo, Kirk, Valant, Jason, Todd, Mary B., Mehra, Maneesha, Filleur, Stephanie

Journal:

Year:

2015

Language:

english

File:

PDF, 437 KB

english, 2015

19

Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment

Basch, Ethan, Deal, Allison M., Dueck, Amylou C., Scher, Howard I., Kris, Mark G., Hudis, Clifford, Schrag, Deborah

Journal:

JAMA The Journal of the American Medical Association

Year:

2017

Language:

english

File:

PDF, 126 KB

english, 2017

20

Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma

Paul M. Dodd, John A. McCaffrey, Madhu Mazumdar, Howard Scher, Vaia Vlamis, Geralyn Higgins, Harry Herr, Dean F. Bajorin

Journal:

Year:

1999

Language:

english

File:

PDF, 78 KB

english, 1999

21

Assessing outcomes in prostate cancer clinical trials : A twenty-first century Tower of Babel

Gretchen A. Gignac, Michael J. Morris, Glenn Heller, Lawrence H. Schwartz, Howard I. Scher

Journal:

Year:

2008

Language:

english

File:

PDF, 184 KB

english, 2008

22

Functional dissection of transcriptional profiles in androgen-dependent and -independent prostate cancer

Amler, Lukas, Agus, David, Dracopoli, Nicholas, Scher, Howard, Hampton, Garret

Journal:

Nature Genetics

Year:

2001

Language:

english

File:

PDF, 28 KB

english, 2001

23

A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study

Robert W Ross, Matthew D Galsky, Howard I Scher, Jay Magidson, Karl Wassmann, Gwo-Shu Mary Lee, Leah Katz, Sumit K Subudhi, Aseem Anand, Martin Fleisher, Philip W Kantoff, William K Oh

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 423 KB

english, 2012

24

785 EFFICACY OUTCOMES BY BASELINE PROSTATE-SPECIFIC ANTIGEN (PSA): RESULTS FROM THE PHASE 3 AFFIRM TRIAL

Saad, Fred, de Bono, Johann S., Shore, Neal D., Fizazi, Karim, Hirmand, Mohammad, Forer, David, Scher, Howard I.

Journal:

The Journal of Urology

Year:

2013

Language:

english

File:

PDF, 432 KB

english, 2013

25

PD27-03 RADICAL PROSTATECTOMY AS A COMPONENT OF MULTIMODAL THERAPY FOR HIGHLY-SELECTED M1 PROSTATE CANCER PATIENTS

O'Shaughnessy, Matthew J., Touijer, Karim A., Eastham, James A., Bochner, Bernard H., Laudone, Vincent P., Scardino, Peter T., Scher, Howard I.

Journal:

The Journal of Urology

Year:

2014

Language:

english

File:

PDF, 41 KB

english, 2014

26

Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses

Ulmert, David, Vickers, Andrew J., Scher, Howard I., Becker, Charlotte, Iversen, Peter, Frankel, David, Jensen, Jens-Kristian, Olesen, Tine Kold, Lilja, Hans

Journal:

Clinical Chemistry and Laboratory Medicine

Year:

2012

Language:

english

File:

PDF, 219 KB

english, 2012

27

Principles of Oncology and Immunology, and Tumors of Bladder, Penis and Urethra

Scher, Howard I.

Journal:

The Journal of Urology

Year:

1994

Language:

english

File:

PDF, 217 KB

english, 1994

28

Principles of Oncology and Immunology, and Tumors of Bladder, Penis and Urethra

Scher, Howard I.

Journal:

The Journal of Urology

Year:

1993

Language:

english

File:

PDF, 6.21 MB

english, 1993

29

The role of lineage plasticity in prostate cancer therapy resistance

Beltran, Himisha, Hruszkewycz, Andrew, Scher, Howard I., Hildesheim, Jeffrey, Isaacs, Jennifer, Yu, Evan Y, Kelly, Kathleen, Lin, Daniel, Dicker, Adam P., Arnold, Julia T, Hecht, Toby T., Wicha, Max S

Journal:

Clinical Cancer Research

Year:

2019

Language:

english

File:

PDF, 1.23 MB

english, 2019

30

Increased survival with high-dose multifield radiotherapy and intensive chemotherapy in limited small cell carcinoma of the lung

Brenda Shank, Howard Scher, Basil S. Hilaris, Carl Pinsky, Michelle Martin, Robert E. Wittes

Journal:

Year:

1985

Language:

english

File:

PDF, 813 KB

english, 1985

31

Phase II trial of gallium nitrate in previously treated patients with small cell lung cancer

Jose Baselga, Mark G. Kris, Howard I. Scher, Mary Phillips, Robert T. Heelan

Journal:

Investigational New Drugs

Year:

1993

Language:

english

File:

PDF, 127 KB

english, 1993

32

The Brief Pain Inventory and Its “Pain At Its Worst in the Last 24 Hours” Item: Clinical Trial Endpoint Considerations

Thomas M. Atkinson, Tito R. Mendoza, Laura Sit, Steven Passik, Howard I. Scher, Charles Cleeland, Ethan Basch

Journal:

Year:

2010

Language:

english

File:

PDF, 180 KB

english, 2010

33

Transectal sonography for serial evaluationof prostatic malignancy

D. David Dershaw, Howard I. Scher, Tracy Smart

Journal:

Year:

1990

Language:

english

File:

PDF, 935 KB

english, 1990

34

Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer

Scher, Howard I., Graf, Ryon P., Schreiber, Nicole A., McLaughlin, Brigit, Lu, David, Louw, Jessica, Danila, Daniel C., Dugan, Lyndsey, Johnson, Ann, Heller, Glenn, Fleisher, Martin, Dittamore, Ryan

Journal:

European Urology

Year:

2016

Language:

english

File:

PDF, 1.73 MB

english, 2016

35

Phase II trial of SM-88, a cancer metabolism based therapy, in non-metastatic biochemical recurrent prostate cancer

Gartrell, Benjamin A., Roach, Mack, Retter, Avi, Sokol, Gerald H., Del Priore, Giuseppe, Scher, Howard I.

Journal:

Investigational New Drugs

Year:

2020

File:

PDF, 1.04 MB

2020

36

Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer

Susan F. Slovin, Govind Ragupathi, Cristina Musselli, Celina Fernandez, Meghan Diani, David Verbel, Samuel Danishefsky, Philip Livingston, Howard I. Scher

Journal:

Cancer Immunology, Immunotherapy

Year:

2005

Language:

english

File:

PDF, 378 KB

english, 2005

37

Editorial

Kirby, Roger, Scher, Howard, Brawer, Mike

Journal:

Prostate Cancer and Prostatic Diseases

Year:

1997

Language:

english

File:

PDF, 22 KB

english, 1997

38

Gene Expression Analysis of Human Prostate Carcinoma during Hormonal Therapy Identifies Androgen-Responsive Genes and Mechanisms of Therapy Resistance

Jeff Holzbeierlein, Priti Lal, Eva LaTulippe, Alex Smith, Jaya Satagopan, Liying Zhang, Charles Ryan, Steve Smith, Howard Scher, Peter Scardino, Victor Reuter, William L. Gerald

Journal:

The American Journal of Pathology

Year:

2004

Language:

english

File:

PDF, 1.23 MB

english, 2004

39

705 ABIRATERONE ACETATE PLUS LOW-DOSE PREDNISONE HAS A FAVORABLE SAFETY PROFILE, IMPROVES SURVIVAL AND PRODUCES PSA AND RADIOGRAPHIC RESPONSES IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PROGRESSING AFTER DOCETAXEL-BASED CHEMOTHERAPY: RESULTS FROM COU-AA-301, A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III STUDY

Saad, Fred, de Bono, Johann S., Haqq, Christopher M., Logothetis, Christopher J., Fizazi, Karim, Jones, Robert J., Chi, Kim N., Kheoh, Thian, Scher, Howard I., Molina, Arturo

Journal:

The Journal of Urology

Year:

2011

Language:

english

File:

PDF, 56 KB

english, 2011

40

Management of Biochemical Recurrence After Primary Treatment of Prostate Cancer: A Systematic Review of the Literature

Punnen, Sanoj, Cooperberg, Matthew R., D’Amico, Anthony V., Karakiewicz, Pierre I., Moul, Judd W., Scher, Howard I., Schlomm, Thorsten, Freedland, Stephen J.

Journal:

European Urology

Year:

2013

Language:

english

File:

PDF, 693 KB

english, 2013

41

MORPHOLOGIC CHARACTERISTICS AT THE TIME OF PROSTATECTOMY IN LYMPH NODE POSITIVE PATIENTS

Tokuda, Yuji, Kaag, Matthew, Gopalan, Anuradha, Tickoo, Satish K, Guillonneau, Bertrand, Eastham, James A, Scher, Howard I, Scardino, Peter T, Reuter, Victor E, Fine, Samson W

Journal:

The Journal of Urology

Year:

2009

Language:

english

File:

PDF, 99 KB

english, 2009

42

Controversies in Treatment of Small Cell Carcinoma of the Lung

Shank, Brenda, Scher, Howard I.

Journal:

Cancer Investigation

Year:

1985

Language:

english

File:

PDF, 1.59 MB

english, 1985

43

Biomarker development in the context of urologic cancers

Kelloff, Gary J., Sigman, Caroline C., Scher, Howard I.

Journal:

Urologic Oncology: Seminars and Original Investigations

Year:

2015

Language:

english

File:

PDF, 277 KB

english, 2015

44

Urological cancer: CHAARTED/GETUG 12—docetaxel in non-castrate prostate cancers

Teo, Min Yuen, Scher, Howard I.

Journal:

Nature Reviews Clinical Oncology (formerly Nature Clinical Practice Oncology)

Year:

2015

Language:

english

File:

PDF, 119 KB

english, 2015

45

Workgroup 3: Transgenic and reconstitution models of prostate cancer

Green, Jeffrey E., Greenberg, Norman M., Ashendel, Curtis L., Barrett, J. Carl, Boone, Charles, Getzenberg, Robert H., Henkin, Jack, Matusik, Robert, Janus, Todd J., Scher, Howard I.

Journal:

Year:

1998

Language:

english

File:

PDF, 69 KB

english, 1998

46

Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862) : Trial results and interleukin-6 analysis: A study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 Consortium

Deborah Bradley, Dana Rathkopf, Rodney Dunn, Walter M. Stadler, Glenn Liu, David C. Smith, Roberto Pili, James Zwiebel, Howard Scher, Maha Hussain

Journal:

Year:

2009

Language:

english

File:

PDF, 163 KB

english, 2009

47

A peptidomimetic inhibitor ofrasfunctionality markedly suppresses growth of human prostate tumor xenografts in mice. Prospects for long-term clinical utility

F. M. Sirotnak, Laura Sepp-Lorenzino, Nancy E. Kohl, Neal Rosen, Howard I. Scher

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2000

Language:

english

File:

PDF, 102 KB

english, 2000

48

A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer

Dana Rathkopf, Bryan Y. Wong, Robert W. Ross, Aseem Anand, Erika Tanaka, Margaret M. Woo, Jing Hu, Andy Dzik-Jurasz, Wei Yang, Howard I. Scher

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2010

Language:

english

File:

PDF, 378 KB

english, 2010

49

A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease

Vanessa C. Thompson, Tanya K. Day, Tina Bianco-Miotto, Luke A. Selth, Guangzhou Han, Mervyn Thomas, Grant Buchanan, Howard I. Scher, Colleen C. Nelson, the Australian Prostate Cancer BioResource, Norm

Journal:

International Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 1.56 MB

english, 2012

50

Population pharmacokinetic analysis of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in adult patients with solid tumors

Aregbe, Abdulateef O., Sherer, Eric A., Egorin, Merrill J., Scher, Howard I., Solit, David B., Ramanathan, Ramesh K., Ramalingam, Suresh, Belani, Chandra P., Ivy, Percy S., Bies, Robert R.

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2012

Language:

english

File:

PDF, 215 KB

english, 2012

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски